ketoconazole has been researched along with paromomycin in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Carvalho, L; Castanys, S; Gamarro, F; Manzano, JI; Pérez-Victoria, JM | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Zijlstra, EE | 1 |
| Cook, GC | 1 |
| Baydar, I; Ozgoztasi, O | 1 |
| Balaña-Fouce, R; Cubría, JC; Ordóñez, D; Reguera, RM | 1 |
| Bauer, BE; Chen, XJ; Clark-Walker, GD; Kuchler, K | 1 |
| Berman, J | 1 |
3 review(s) available for ketoconazole and paromomycin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The pharmacology of leishmaniasis.
Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Drug Design; Humans; Itraconazole; Ketoconazole; Leishmania; Leishmaniasis; Paromomycin; World Health Organization | 1998 |
Clinical status of agents being developed for leishmaniasis.
Topics: Aminoquinolines; Antiprotozoal Agents; Fluconazole; Humans; Imiquimod; Ketoconazole; Leishmaniasis; Paromomycin; Phosphorylcholine | 2005 |
2 trial(s) available for ketoconazole and paromomycin
| Article | Year |
|---|---|
The treatment of kala-azar: old and new options.
Topics: Amphotericin B; Antimony; Humans; Ketoconazole; Leishmaniasis, Visceral; Paromomycin | 1992 |
A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey.
Topics: Administration, Oral; Administration, Topical; Amebicides; Animals; Child; Child, Preschool; Female; Humans; Ketoconazole; Leishmania tropica; Leishmaniasis, Cutaneous; Male; Paromomycin; Trypanocidal Agents | 1997 |
6 other study(ies) available for ketoconazole and paromomycin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Increased glycolytic ATP synthesis is associated with tafenoquine resistance in Leishmania major.
Topics: Adenosine Triphosphate; Aminoquinolines; Antiprotozoal Agents; Drug Resistance; Glycolysis; Leishmania major; Pyruvate Kinase | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Leishmaniasis: some recent developments in chemotherapy.
Topics: Allopurinol; Amphotericin B; Antiprotozoal Agents; Humans; Ketoconazole; Leishmaniasis; Paromomycin | 1993 |
Positive and negative control of multidrug resistance by the Sit4 protein phosphatase in Kluyveromyces lactis.
Topics: 4-Nitroquinoline-1-oxide; Antifungal Agents; Antimycin A; Drug Resistance, Multiple; Econazole; Genetic Complementation Test; Genotype; Ketoconazole; Kluyveromyces; Molecular Sequence Data; Oligomycins; Paromomycin; Phosphoprotein Phosphatases; Protein Phosphatase 2; Restriction Mapping; Saccharomyces cerevisiae Proteins; Sorbic Acid; Tacrolimus | 2000 |